跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BIMATOPROST/TIMOLOL GENETIC 0,3 MG/ML + 5 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BIMATOPROST/TIMOLOL GENETIC 0,3 MG/ML + 5 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS
Approved
STANDARD
BIMATOPROST/TIMOLOL GENETIC 0,3 MG/ML + 5 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS
Genetic S.P.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 1, 2022
Approval ID
0df843a762ec1114
Company
Genetic S.P.A.
Type
Standard
Approval Details
Approval Id
0df843a762ec1114
Drug Cima Aemps Name
BIMATOPROST/TIMOLOL GENETIC 0,3 MG/ML + 5 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS
Register Number
87926
Holder Company Name
Genetic S.P.A.
Marketing Company Name
Genetic S.P.A.
Authorization Date
2022-07-01
Dosage Form
COLIRIO EN SOLUCIÓN EN ENVASE UNIDOSIS
Dose
0,3 mg/ml + 5 mg/ml
Route Of Administration
VÍA OFTÁLMICA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Genetic S.P.A.
Active Ingredients
BIMATOPROST
0,3 mg/ml
TIMOLOL MALEATO
6,83 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 1, 2022
Approval ID
0df843a762ec1114
Type
Standard
Back to CIMA-AEMPS Approvals